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Dr. Gerald Meyer Emphasizes “Courage” at the American Society of 
Health System Pharmacists 
The following is an excerpt of an inaugural 
address given by Gerald E. Meyer, 
PharmD, MBA, FASHP, new President of 
the American Society of Health System 
Pharmacists (ASHP), at the Opening 
Session of ASHP’s Summer Meeting in 
Minneapolis, MN, June 4, 2013. Included 
in this excerpt are highlights from questions 
submitted from ASHP members. Dr. Meyer 
is Director of Experiential Education at the 
Jefferson School of Pharmacy.
I would like to begin by acknowledging 
you—our members. I want to personally 
thank all of the members who have 
participated in ASHP’s state societies. 
ASHP could not fulfill its mission without 
the support and inspired leadership of our 
affiliates. Yes, being president of ASHP 
involves a lot of time and travel. But it also 
comes with a large support staff.
The volunteer leaders in our affiliates, 
on the other hand, do it all. You are the 
membership committee, the program 
committee, the finance committee, the 
professional advocacy committee, the 
strategic planning committee, and so much 
more. So, to all of you, a great big thanks!
A Rich Pharmacy History
Many of you may know that I am from 
Philadelphia. And I am proud of it.
Philadelphia has a very rich pharmacy 
history. We have the first hospital in the 
United States—Pennsylvania Hospital — 
founded by Benjamin Franklin in 1751. 
We have the first college of pharmacy 
in the United States—the Philadelphia 
College of Pharmacy, which opened 
in 1821. And we had the first hospital 
pharmacist in the United States. His name 
was Jonathan Roberts.
We also lay claim to the first Hospital 
Pharmacy Residency Program to be 
surveyed for ASHP accreditation and 
the first accredited Pharmacy Technician 
Training Program, both at Thomas 
Jefferson University Hospital.
We have four past-presidents of ASHP 
currently working in Philadelphia and a 
fifth in retirement nearby. I have been truly 
fortunate to have had access to so many 
health-system pharmacy leaders. 
I am most appreciative for the inspiration, 
support, and encouragement that I have 
received from numerous professional 
colleagues – including more than 230 
pharmacy residents –  at Thomas Jefferson 
University Hospital and Thomas Jefferson 
University with whom I have had the 
privilege to work. And, most importantly, 
I am thankful for the wonderful personal 
support from my wife, Cheryl, my sons 
Kevin and David, and many family 
members and friends.
Top Priorities
In writing this speech, I definitely had a 
lot of people to call upon. Yet, as much 
as I value their wisdom, I did not ask a 
single one of them for guidance on what 
I should talk about today. Rather, I asked 
you, the members. ASHP is a membership 
organization. It is owned by you, its 
members. So I felt it was appropriate to 
focus our discussion today on those issues 
that are of greatest importance to you.
We sent out a survey to a random sample 
of ASHP members and asked: “What 
question would you like to ask Gerry 
Meyer?” Well, you did not disappoint. We 
received 130 questions, many of which 
spoke to the concept of courage. 
“What will be your top priorities as 
incoming president of ASHP?”
I have a list of priorities to share with you. 
But my priorities are of little value unless 
they become our priorities. My top priority, 
therefore, is to be the best leader I can possibly 
be. And you can’t lead without a vision. 
What makes a good leader?
•  The ability to articulate a vision,
•  The ability to motivate others toward 
that vision, and
•  The ability to remove obstacles to 
promote achievement of the vision.
Now, who among you can recite ASHP’s 
vision? ASHP’s vision is that medication 
use will be optimal, safe and effective 
for all people, all of the time. There’s no 
mention of “hospitals” or “health systems.” 
There’s not even mention of “patients.” It 
says “all people, all of the time.”
Here is my list of priorities for the year. I 
would suggest that we view most of the 
individual items on this list as obstacles 
confronting us in our efforts to accomplish 
ASHP’s vision:
•  Build coalitions
•  Implement the recommendations of the 
Pharmacy Practice Model Initiative
•  Pursue provider status
•  Promote interprofessional education 
and practice
•  Expand training and certification for 
pharmacists and pharmacy technicians
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•  Position ASHP to be as nimble 
as possible in a rapidly changing 
environment, and…
•  World peace!
There’s a reason for the last item on  
the list. Creating an environment in  
which medication use will be optimal,  
safe and effective for all people, all of  
the time is a bold and expansive 
vision. And just because it is hard to 
conceptualize, we cannot be deterred 
from putting our energies towards its 
achievement. (So, in that respect, our 
vision is a bit like world peace.)
Antagonism vs. Synergism
“We see a push to work collaboratively 
with other health care providers but seem 
to have a difficult time putting this into 
practice. Are there ways to accelerate 
this interprofessional practice? Perhaps 
through pharmacy education and post-
graduate residency programs?”
By definition, interprofessional activities 
clearly cannot be accomplished by one 
profession. Each profession must be 
willing to participate.
The good news is that in May 2011, 
a group called the Interprofessional 
Education Collaborative—consisting 
of educators representing pharmacy, 
medicine, nursing, dentistry, and public 
health—released a report that summarized 
the core competencies needed for 
interprofessional collaborative practice. 
Those core competencies fell within  
four domains:
1. Values and ethics
2. Roles and responsibilities
3. Interprofessional communication 
4. Teams and teamwork
What this report says is that to build an 
efficient and effective health care system, 
health care providers need to:
•  Have a common understanding of 
health care ethics and values
•  Understand one another’s roles and 
responsibilities
•  Learn how to communicate with one 
another, and
•  Learn how to be part of effective  
teams and how to play well together  
in the sandbox.
For two years, we have had this guidance 
document that delineates the curricular 
components that should be taught to 
health care students, interprofessionally. 
Our profession needs to take a leadership 
position in incorporating interprofessional 
competencies into our formal education 
and training standards. These changes 
cannot occur fast enough. Furthermore, to 
develop this set of skills and knowledge 
within practicing pharmacists, ASHP 
must incorporate this critical content 
within our continuing professional 
development offerings.
It’s important to consider what this 
report does not say. Nowhere does it say 
that interprofessional education should 
encompass getting health care students 
into the same classroom to teach them 
pathophysiology, pharmacology, diagnosis, 
or treatment. So, if those are not our 
commonalities, then those must be our 
differences. Exactly.
Let’s look at this in pharmacologic terms. 
Sometimes, we administer two very 
effective drugs that may compete for 
the same receptor, and the result is that 
they become less effective. We call that 
phenomenon “antagonism.” On the other 
hand, sometimes we prescribe two drugs 
and the positive effect is greater than the 
anticipated sum of their individual effects. 
We call that “synergism.”
Let’s move past interprofessional 
antagonism. Let’s have the courage to 
promote an efficient and effective health 
care system comprised of interdependent, 
synergistic health care providers.
The Future of Residency Training
Among the questions I received, more 
related to residencies than to any other 
topic. Two members asked: “How does 
ASHP plan to help grow the number of 
residency programs and the number of 
available positions? And, how can the 
accreditation process be simplified?”
Although it sometimes may feel like we 
are making little progress in this area, the 
numbers tell a different story. From 1995 
to 2006 (a 12-year period), the number of 
available accredited residency programs 
and the number of available positions in 
those programs doubled. From 2006 to 
2012 (a subsequent 6-year period), the 
number of accredited residency programs 
and number of positions doubled again.
Part of the reason for this rapid growth is 
that the value proposition for residencies is 
easily developed for residents, employers, 
patients, and the profession. The ASHP 
website contains a number of documents 
that can assist practitioners in justifying, 
designing, and conducting residency 
training programs.
However, one of the greatest barriers to 
increasing the number of residency training 
programs cannot be overcome with 
guidance documents alone. A good training 
program requires a solid infrastructure.
Pharmacy services must meet 
contemporary standards of practice. 
Preceptors must have the ability to impart 
knowledge and develop critical reasoning 
skills. Residency program directors 
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must be able to mentor and inspire 
those entering the profession. And an 
organization’s culture must be supportive 
of the training mission. We cannot, and 
we should not, compromise on these 
foundational pillars.
While ASHP’s residency policy is 
aspirational in nature and the decision 
about whether to pursue a residency is 
a career decision and you do not need a 
residency to obtain a pharmacist license; 
you do need a residency to pursue and 
advance along certain career paths and the 
number of those career paths continues to 
grow every year.
There are four stages to the education 
and continued training of a pharmacist: 
pre-pharmacy undergraduate education, 
professional doctorate education, 
formalized training, and continuing 
professional development. Coordinating 
the outcomes of each of these four stages 
is a professional imperative. Yes; the 
requirements for the pre-pharmacy and 
pharmacy curricula will continue to 
evolve; but, we must recognize that there 
is only so much that we can accomplish 
in the classroom because (1) contact time 
is limited, and (2) students do not have 
pharmacist licenses.
At some point in time, the profession 
will need to address the question: Should 
residency training be required for 
pharmacists to meet their obligation to 
their patients? At some point, that answer 
will be “yes.” Whether this happens 
by 2020 or not, it is far better for the 
profession to prepare for that future than to 
be unprepared when that future arrives.
Gaining Provider Status
“When are pharmacists finally going to  
be recognized as providers, and what will 
it change?”
Many of you may have attended the 
Provider Status Town Hall at this Summer 
Meeting where this very issue was 
discussed. Much of what we heard, we 
already knew:
•  The health care environment is changing.
•  Emerging practice models are focused on 
integrated health care delivery systems.
•  Policymakers are seeking ways to 
make health care more affordable for 
more people.
•  Payment will be focused on quality, 
not quantity, of care.
•  Consumers will demand transparency 
in the cost of their care.
So, what will happen when pharmacists 
are recognized as health care providers?
•  Pharmacists’ patient care services will 
improve access.
•  Pharmacists’ patient care services will 
improve quality.
•  Pharmacists’ patient care services 
will help control costs. Access—
quality—cost. There is substantial 
documentation to support the positive 
impact of pharmacists on access, 
quality and cost of care. We know it. 
Now we have to sell it. We must have 
the courage of our convictions.
The first step towards achieving provider 
status is to ensure that the profession 
moves forward with this common 
message by solidifying these basic 
principles within the existing coalition of 
pharmacy organizations. Then, we need 
to expand the coalition to include other 
critical stakeholders, including health 
care provider groups, payers, and patient 
advocates. We need to draft legislation and 
seek support by educating legislators, both 
on a state and national level.
ASHP will serve as your collective voice 
in formulating the message. ASHP will 
develop the materials needed to deliver that 
message. ASHP will tailor those materials 
for different audiences. And ASHP will train 
you. But, we need you to deliver the message 
to your legislators, to your C-suite, to your 
health-system’s lobbyists, to your health care 
colleagues, to your complacent pharmacist 
colleagues, to your local media, and to 
your patients. Access—quality—cost. The 
message is clear. The message is focused. 
The message meets society’s needs.
Gaining provider status will ensure that 
pharmacy is at the table when regulators 
and other policymakers invite health care 
providers to help construct new delivery 
models. And that is why ASHP, the American 
Pharmacists Association (APhA), the 
American College of Clinical Pharmacy 
(ACCP), and other health care organizations 
have committed significant resources to 
achieving provider status for pharmacists.
While no one can predict when we will 
finally succeed, I am confident that we will 
succeed if we have the courage to stand 
strong and united on this issue and if our 
members get personally involved.
I call upon all pharmacists who believe they 
are health care providers, on all student 
pharmacists who believe they are training 
to become health care providers, on all 
people who want their medication use to be 
optimal, safe and effective all of the time. 
I call on everyone to send the message: 
“Pharmacists are medication-use experts. 
Pharmacists improve access, improve 
quality, and control the cost of health care. 
Pharmacists are health care providers.”
In closing, I want to thank everyone who 
took the time to submit questions. I invite 
you to continue to send me your comments 
and suggestions over the next year. Send 
your emails to:  prez@ashp.org. 
Finally, I want to thank you for the courage 
you show every day toward advancing 
ASHP’s vision: that medication use will be 
optimal, safe and effective for all people, 
all of the time. 
